Source: Lancet
Area: News
This review article looks at the epidemiology, genetics and pathogenesis, clinical features and classification, prevention and treatment of age-related macular degeneration (AMD), a major cause of blindness worldwide. Treatments reviewed include laser photocoagulation, photodynamic therapy (PDT), anti-VEGF therapy (pegaptanib, ranibizumab, bevacizumab, aflibercept). Finally the authors discuss new research in the treatment of this disease, and its possible implications.
Uncategorized